Kazano 12.5 mg

KAZANO 12.5 MG tablets contain alogliptin (alogliptin benzoate), a medication used to manage type 2 diabetes. This oral tablet helps control blood sugar levels when combined with diet and exercise. Ideal for those seeking effective diabetes management.

KAZANO 12.5 MG tablets are primarily used to manage type 2 diabetes. Alogliptin works by increasing insulin production and decreasing sugar production in the liver. This medication is often prescribed alongside diet and exercise to help control blood sugar levels. It is not intended for type 1 diabetes or diabetic ketoacidosis.

Common effects of KAZANO 12.5 MG tablets may include headache, nasal congestion, and upper respiratory tract infection. Some users might experience gastrointestinal issues like nausea or diarrhea. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

KAZANO 12.5 MG tablets should be stored at room temperature, away from moisture and heat. Keep out of reach of children. Inform your healthcare provider about any allergies or other medications you are taking. Do not alter your dosage without professional guidance.

KAZANO 12.5 MG tablets may interact with certain medications, including other diabetes drugs, antibiotics, and antifungal agents. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always consult a healthcare provider before starting any new medication.